Crossmark

Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50 years

Crossref DOI link: https://doi.org/10.1186/s13058-019-1143-y

Published Online: 2019-05-06

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Petridis, Christos

Arora, Iteeka

Shah, Vandna

Megalios, Anargyros

Moss, Charlotte

Mera, Anca

Clifford, Angela

Gillett, Cheryl

Pinder, Sarah E.

Tomlinson, Ian

Roylance, Rebecca

Simpson, Michael A.

Sawyer, Elinor J. https://orcid.org/0000-0001-8285-4111
Funding

Funding for this research was provided by:

Breast Cancer Now (Breast Cancer Campaign 2011NovPR49)

Kings College London (King’s Health Partner’s Research and Development Challenge Fund (R150505))

Cancer Research UK (8873)
License Information

Text and Data Mining valid from 2019-05-06
More Information

Article History

Received: 6 September 2018

Accepted: 17 April 2019

First Online: 6 May 2019

Ethics approval and consent to participate

: All patients and controls were recruited through the following ethically approved studies and gave consent to genetic testing (GLACIER study, MREC 06/Q1702/64; ICICLE, MREC 08/H0502/4; King’s Health Partners breast tissue bank, NHS REC ref.-EE-0493).

: Not applicable.

: The authors declare that there is no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below